Viatris Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Viatris Inc with three other companies in this sector in UNITED STATES : Zoetis Inc (2020 sales of $6.68 billion of which 53% was US), Regeneron Pharmaceuticals Incorporated ($8.50 billion of which 58% was EYLEA), and Vertex Pharmaceuticals Inc ($6.21 billion of which 62% was TRIKAFTA).

Sales Analysis. During the year ended December of 2020, sales at Viatris Inc were $11.95 billion. This is an increase of 3.9% versus 2019, when the company's sales were $11.50 billion.